Dean Riley

Title: Dean Riley - Innovator in Pharmaceutical Chemistry

Introduction

Dean Riley is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work has led to advancements that are beneficial in the development of medications.

Latest Patents

Dean Riley holds a patent for a process titled "Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine." This innovative process focuses on the racemization of enantiomerically enriched 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine, which serves as a useful intermediate in the preparation of paroxetine. The formula indicates that the compound has an enantiomeric excess of one enantiomer over the other.

Career Highlights

Throughout his career, Dean has demonstrated a strong commitment to advancing pharmaceutical research. His patent reflects his expertise and innovative approach to solving complex chemical challenges. He is currently associated with Aesica Pharmaceuticals Limited, where he continues to contribute to the field.

Collaborations

Dean has worked alongside talented colleagues, including Jayne Froggett and Andrew Turner. Their collaborative efforts have further enhanced the research and development initiatives within their organization.

Conclusion

Dean Riley's contributions to pharmaceutical chemistry, particularly through his patented process, highlight his role as an innovator in the industry. His work not only advances scientific knowledge but also plays a crucial role in the development of effective medications.